Springer

SHERPA: Unknown

People

  1. Morrow
    Morrow
  2. D'Angelica
    D'Angelica
  3. Jarnagin
    Jarnagin
  4. Brennan
    Brennan
  5. Gonen
    Gonen
  6. Kingham
    Kingham
  7. Coit
    Coit
  8. Sevilimedu Veeravalli
    Sevilimedu Veeravalli
  9. Weiser
    Weiser
  10. Van Zee
    Van Zee

Groups

  1. Surgery (2732)
  2. Department of Medicine (1644)
  3. Survivorship Research (1571)
  4. Population Sciences Research Program (1134)
  5. Solid Tumor Oncology Division (992)
  6. Epidemiology and Biostatistics (945)
  7. Radiology, Department of (941)
  8. Center for Pancreatic Cancer Research (850)
  9. Sloan Kettering Institute Postdocs (840)
  10. GSK Faculty (714)
Search Within
Formats
  1. Journal Article (4229)
  2. Meeting Abstract (1213)
  3. Book Section (1017)
  4. Review (300)
  5. Editorial (188)
  6. Miscellaneous (133)
  7. Conference Paper (95)
  8. Book Whole (60)
  9. Guidelines (36)
  10. Research Letter (20)
  11. Correspondence (16)
Groups
  1. Surgery (2732)
  2. Department of Medicine (1644)
  3. Survivorship Research (1571)
  4. Population Sciences Research Program (1134)
  5. Solid Tumor Oncology Division (992)
  6. Epidemiology and Biostatistics (945)

More Groups

People
  1. Monica Morrow (342)
  2. Michael D'Angelica (256)
  3. William Jarnagin (254)
  4. Mithat Gonen (238)
  5. Murray Brennan (224)
  6. T Peter Kingham (185)

More People

Years
  1. 2025 (246)
  2. 2024 (363)
  3. 2023 (375)
  4. 2022 (443)
  5. 2021 (381)
  6. 2020 (353)

More Years

Publications
  1. Annals of Surgical Oncology (1729)
  2. Breast Cancer Research and Treatment (355)
  3. Annals of Behavioral Medicine (295)
  4. Journal of Neuro-Oncology (213)
  5. European Journal of Nuclear Medicine and Molecular Imaging (196)
  6. European Radiology (129)

More Publications

Results (7307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between alert notification intensity during early study participation and time to study discontinuation in the AFT-39 PRO-TECT cluster-randomized clinical trial
    Meeting Abstract

    Ginos, B.; Dueck, A. C.; Schrag, D.; Jansen, J.; Henson, S.; Stover, A. M.; Carr, P.; Spears, P. A.; Jonsson, M.; Deal, A. M.; more...
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Artificial intelligence in GPT-4 can interpret cancer patients' prognosis awareness without training: A zero-shot learning task
    Meeting Abstract

    Li, Y.; Petrov, A.; Aktinson, T. M.; Lynch, K. A.; George, L.; Kuperman, G.; Li, A.; Flory, J.; Stetson, P.
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Promoting implementation of patient-reported outcomes in institutions caring for vulnerable and underserved cancer populations
    Meeting Abstract

    Schuster, A.; Crossnohere, N.; Vickers, A.; Vargo, M.; Smith, E.; Smith, C.; Sibbitt, B.; Shapiro, L.; Richardson, A.; Rainey, A. M.; more...
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Global response score correlates with quality of life in cutaneous T-cell lymphoma
    Meeting Abstract

    Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M.; Larocca, C.; Querfeld, C.; Zain, J.; Horwitz, S.
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • In-situ (90)Y microdosimetry and biological effects at microscopic level after transarterial radioembolization
    Meeting Abstract

    Kirov, A.; Carter, L.; Talarico, O.; Teplov, A.; Vakiani, E.; Lafontaine, D.; Kunin, H.; Chan, E.; Nehmeh, M.; Dimopoulos, M. P.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Bone marrow dosimetry exploratory analysis from the phase 3 SIERRA trial of (131)I-apamistamab prior to HCT in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M.; Leung, E.; Spross, J.; Li, K.; Desai, A.; Brodin, P.; Wahl, R.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • A recovery coefficient model for resolution characterization, harmonization, and shape-specific partial volume correction
    Meeting Abstract

    Marquis, H.; Schmidtlein, C. R.; de Nijs, R.; Mínguez Gabiña, P.; Gustafsson, J. R.; Ocampo Ramos, J. C.; Kayal, G.; Carter, L. M.; Bailey, D. L.; Kesner, A. L.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Tumour dosimetry across 6 cycles of [(177)Lu]LuPSMA-617 in patients with metastatic castrationresistant prostate cancer: Results from the VISION substudy
    Meeting Abstract

    Herrmann, K.; Krause, B.; Chi, K.; Sartor, O.; Fizazi, K.; Morris, M. J.; De Bono, J.; Tagawa, S.; Kurth, J.; Eiber, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Development of PET response criteria in neuroendocrine tumors (PERCIN)
    Meeting Abstract

    Chaban, A.; Dinkel, V.; Eiber, M.; Song, Y.; Brosch-Lenz, J.; Krebs, S.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Targeting fibroblast activation protein using radioactively tagged sibrotuzumab
    Meeting Abstract

    Ingham, A.; De Gregorio, R.; Viray, T.; Loor, A.; Harris, M.; Lewis, J. S.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save